Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Oncotarget|February 4, 2016
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancerJames DuHadaway, George C PrendergastJournal of Cellular Biochemistry|October 15, 2013
Specific in situ detection of murine indoleamine 2, 3-dioxygenaseSunil Thomas, James DuHadaway, George C Prendergast, et al.Digestive Diseases and Sciences|July 22, 2015
Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier FunctionSunil Thomas, Joanna M Mercado, James DuHadaway, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunityGrant N Scott, James DuHadaway, Elizabeth Pigott, et al.Journal of Medicinal Chemistry|January 20, 2006
Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitorsPaul Gaspari, Tinku Banerjee, William P Malachowski, et al.Cancer Research|January 20, 2007
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responsesDe-Yan Hou, Alexander J Muller, Madhav D Sharma, et al.Journal for Immunotherapy of Cancer|July 22, 2020
Peptide vaccination directed against IDO1-expressing immune cells elicits CD8<sup>+</sup> and CD4<sup>+</sup> T-cell-mediated antitumor immunity and enhanced anti-PD1 responsesSouvik Dey, Erika Sutanto-Ward, Katharina L Kopp, et al.Pageof 1